~~<i id='69FB6D894D'><strike id='69FB6D894D'><tt id='69FB6D894D'><pre id='69FB6D894D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：focus 2025-09-27 12:57:36 - browse：133

The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA.

None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

Exa-cel, given as a one-time infusion, uses CRISPR genome-editing technology to patch up the genetic faults at the root of sickle cell disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Retired US general questions alleged Putin, Prigozhin meeting

knowledge

entertainment

Wikipedia

knowledge

hotspot

knowledge

0:38AcraneliftsahugeoakframeatNotreDamedePariscathedral,Tuesday,July11,2023inParis.Thepanelsaredueto

WSS

Retired US general questions alleged Putin, Prigozhin meeting

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

As AI in medicine takes off, can 'human in the loop' prevent harm?

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Medicare coverage of Wegovy, once blocked, now looks possible

focus

fashion

knowledge

How one medical school became remarkably diverse

Medicare coverage of Wegovy, once blocked, now looks possible

Medical leaders decry Supreme Court decision on affirmative action

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

The high cost of giving birth even with insurance

Why depression after traumatic brain injury is distinct

23andMe had bad news about my health. I wish a person had delivered it

How the political right came to back psychedelics to treat trauma

Tori Bowie and the unacceptable rates of Black maternal death

What to know about OceanGate, the company behind the missing Titanic submersible

entertainment

Charles Manson follower Leslie Van Houten released from prison after 53 years

Readout Newsletter: Bristol, Sangamo, Gilead, and more

HHS secretary Becerra pressed on Change HealthCare cyberattack

Why scientists need input from humanists on sensitive research

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Wikipedia

knowledge

hotspot

knowledge